Xconomy Xchange: Reinventing Biotech’s Business Model for the Big Apple

Event Location

Apella, Event Space at Alexandria Center, 450 East 29th Street

Event Date & Time

10/4/12
6:30 - 8:30

Share and Comment

Leave a Comment Order a Reprint E-mail this Event

The traditional model of biotech entrepreneurship—building full-service companies with discovery, R&D, and marketing under one roof—has proven especially challenging in New York. With wet-lab space scarce and expensive, a dearth of VC funding for early-stage research, and a high cost of living that makes it hard to attract talent, many researchers look elsewhere for entrepreneurial opportunities. But it doesn’t have to be that way. A growing cadre of NYC entrepreneurs are embracing alternative business models that allow them to thrive in the Big Apple. Some are outsourcing everything from basic discovery to development. Others have found funding from disease-oriented foundations, and lab space and office options are growing as well. In this intimate evening forum, we’ll hear from a diverse group of entrepreneurs, venture capitalists, and non-profit leaders who will share valuable insights about everything from recruiting top talent to raising funding—and building a vital life sciences cluster right here in New York.

Confirmed Speakers

Sam Waksal
- Founder & CEO, Kadmon Pharmaceuticals
Kevin Kinsella
- Founder & Managing Director, Avalon Ventures
Jill O’Donnell-Tormey
- CEO and Director of Scientific Affairs, Cancer Research Institute
Dennis Purcell
- Senior Managing Partner, Aisling Capital
Arthur Tinkelenberg
- CEO, Enumeral Biomedical
John Cunningham
- SVP, Regional Market Director, Alexandra Real Estate Equities, Inc.